House Appropriations Committee Adopts Appropriations Bill Granting FDA Increased Funding
On June 18, the House Appropriations Committee marked its Fiscal Year 2010 Agriculture Appropriations Bill. The funding included in the bill for the Food and Drug Administration (FDA) in the bill remained unchanged from the subcommittee-approved version; this means an approximate $300 million increase in funds for the agency. On the surface, this is great news for the FDA, but the upcoming year will see the agency potentially saddled with new regulatory responsibilities. Funding these new responsibilities could detract from monies that would otherwise be used to bolster core programs. A dialogue on increased responsibilities and resource allocation needs to accompany any conversations regarding funding increases before the bill is signed into law. The Senate mark up will take place on July 7. The House may also take further action on the bill by July 9.
ACT-AD to Host Upcoming Scientific Workshop on Clinical Meaningfulness
ACT-AD, together with the Alzheimer’s Association and LEAD (Leaders Engaged in Alzheimer’s Disease), will host a scientific workshop to stimulate an open discussion with FDA officials, scientists, drug developers, academics and advocacy organizations on standards of clinical meaningfulness and exploring novel approaches regarding the state of the science in this vital field. The workshop is a public event and will be held July 21, 2009 from 8:00am to 12:30pm at the Hilton Rockville Executive Meeting Center in Rockville, MD. Additional documents will be circulated following the meeting. For more information, please contact Cynthia Bens [email protected]